143 related articles for article (PubMed ID: 3896570)
1. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications.
Valdes R
Clin Chem; 1985 Sep; 31(9):1525-32. PubMed ID: 3896570
[TBL] [Abstract][Full Text] [Related]
2. Protein binding of endogenous digoxin-immunoactive factors in human serum and its variation with clinical condition.
Valdes R; Graves SW
J Clin Endocrinol Metab; 1985 Jun; 60(6):1135-43. PubMed ID: 3998064
[TBL] [Abstract][Full Text] [Related]
3. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
Dasgupta A; Kang E; Datta P
Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
[TBL] [Abstract][Full Text] [Related]
4. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Matheke ML; Valdes R
Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
[TBL] [Abstract][Full Text] [Related]
5. Endogenous digoxin-immunoreactive substance measured in several patient populations.
Valdes R
Prog Clin Biol Res; 1985; 192():221-8. PubMed ID: 4080710
[TBL] [Abstract][Full Text] [Related]
6. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
Datta P; Dasgupta A
Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
[TBL] [Abstract][Full Text] [Related]
7. Endogenous digoxin-immunoactive factor in human subjects.
Valdes R
Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
[TBL] [Abstract][Full Text] [Related]
8. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
[TBL] [Abstract][Full Text] [Related]
9. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
[TBL] [Abstract][Full Text] [Related]
10. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
Schlebusch H; Jarausch J; Domke I
Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors.
Datta P; Hinz V; Klee G
Clin Biochem; 1996 Dec; 29(6):541-7. PubMed ID: 8939401
[TBL] [Abstract][Full Text] [Related]
12. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
Dasgupta A; Peng Y
Life Sci; 1991; 49(22):1603-9. PubMed ID: 1943464
[TBL] [Abstract][Full Text] [Related]
13. Endogenous digoxin-like factor in neonates: effect of age and relation to serum bilirubin levels.
Wolach B; Carmi D; Shilo L; Dolev S; Shenkman L
Acta Paediatr Scand; 1989 May; 78(3):364-8. PubMed ID: 2545073
[TBL] [Abstract][Full Text] [Related]
14. Endogenous digoxin immunoactivity is elevated in hypertensive pregnancy.
Valdes R; Graves SW; Knight AB; Craig HR
Prog Clin Biol Res; 1985; 192():229-32. PubMed ID: 4080711
[TBL] [Abstract][Full Text] [Related]
15. A new digoxin immunoassay substantially free of interference by digoxin immunoreactive factor.
Jiang F; Wilhite TR; Smith CH; Landt M
Ther Drug Monit; 1995 Apr; 17(2):184-8. PubMed ID: 7624908
[TBL] [Abstract][Full Text] [Related]
16. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
Fitzsimmons WE
Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
[TBL] [Abstract][Full Text] [Related]
17. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
Graves SW; Lincoln K; Cook SL; Seely EW
Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
[TBL] [Abstract][Full Text] [Related]
18. Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay.
Ray JE; Crisan D; Howrie DL
Clin Chem; 1991 Jan; 37(1):94-8. PubMed ID: 1988216
[TBL] [Abstract][Full Text] [Related]
19. Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors.
Azzazy HM; Duh SH; Maturen A; Schaller E; Shaw L; Grimaldi R; Shock G; Christenson RH
Clin Chem; 1997 Sep; 43(9):1635-40. PubMed ID: 9299945
[TBL] [Abstract][Full Text] [Related]
20. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
Lau BW; Valdes R
Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
